THE INFAMOUS MARK OF THE BEAST

THE MARK OF THE BEAST "And that no man might buy or sell, save he that had the mark, or the name of the beast, or the number of his name. 18Here is wisdom. Let him that hath understanding count the number of the beast: for it is the number of a man; and his number is 666. " xáragma ("brand-mark") was originally any impress on a coin or a seal, used by an engraver on a die (stamp, branding iron). 5480 (xáragma) later became "the identification-marker" (like with an owner's unique "brand-mark"). So even though we campaigned against the RFID Microchip implant we did not make the assumption as many did that it fulfilled the criteria of the mark of the beast. It is disinformation and lack of understanding of scripture that lends itself to the "boy who cried wolf' scenario. As Revelations is a moving book , technology is being created to fit the prophecies mentioned thousands of years ago. Enter the Quantum Dot Vaccine brought to us by none other than Gates and MIT. Now this was of immediate interest to us it was a self administered band aid vaccine application with the aim of it being mailed to everyone on the IBM Census and applied by the end user. The amd aid using quantum dot technology is applied to any The Mark of The Beast the most debated topic in Revelations. Some have wrongly linked it to Sunday worship discrediting the financial element of the Mark.. Fact is it is an etch of the skin AND linked to buying and selling. xáragma ("brand-mark") was originally any impress on a coin or a seal, used by an engraver on a die (stamp, branding iron). 5480 (xáragma) later became "the identification-marker" (like with an owner's unique "brand-mark"). Now this Quantum Dot Tattoo through micro needles etches the skin meeting scriptures requirement. How astounding that a book written 2000 years ago is ahead of technology finding its way to the surface. An invisible record Several years ago, the MIT team set out to devise a method for recording vaccination information in a way that doesn’t require a centralized database or other infrastructure. Many vaccines, such as the vaccine for measles, mumps, and rubella (MMR), require multiple doses spaced out at certain intervals; without accurate records, children may not receive all of the necessary doses. “In order to be protected against most pathogens, one needs multiple vaccinations,” Jaklenec says. “In some areas in the developing world, it can be very challenging to do this, as there is a lack of data about who has been vaccinated and whether they need additional shots or not.” To create an “on-patient,” decentralized medical record, the researchers developed a new type of copper-based quantum dots, which emit light in the near-infrared spectrum. The dots are only about 4 nanometers in diameter, but they are encapsulated in biocompatible microparticles that form spheres about 20 microns in diameter. This encapsulation allows the dye to remain in place, under the skin, after being injected. The researchers designed their dye to be delivered by a microneedle patch rather than a traditional syringe and needle. Such patches are now being developed to deliver vaccines for measles, rubella, and other diseases, and the researchers showed that their dye could be easily incorporated into these patches. The microneedles used in this study are made from a mixture of dissolvable sugar and a polymer called PVA, as well as the quantum-dot dye and the vaccine. When the patch is applied to the skin, the microneedles, which are 1.5 millimeters long, partially dissolve, releasing their payload within about two minutes. By selectively loading microparticles into microneedles, the patches deliver a pattern in the skin that is invisible to the naked eye but can be scanned with a smartphone that has the infrared filter removed. The patch can be customized to imprint different patterns that correspond to the type of vaccine delivered. “It’s possible someday that this ‘invisible’ approach could create new possibilities for data storage, biosensing, and vaccine applications that could improve how medical care is provided, particularly in the developing world,” Langer says. An invisible record Several years ago, the MIT team set out to devise a method for recording vaccination information in a way that doesn’t require a centralized database or other infrastructure. Many vaccines, such as the vaccine for measles, mumps, and rubella (MMR), require multiple doses spaced out at certain intervals; without accurate records, children may not receive all of the necessary doses. “In order to be protected against most pathogens, one needs multiple vaccinations,” Jaklenec says. “In some areas in the developing world, it can be very challenging to do this, as there is a lack of data about who has been vaccinated and whether they need additional shots or not.” To create an “on-patient,” decentralized medical record, the researchers developed a new type of copper-based quantum dots, which emit light in the near-infrared spectrum. The dots are only about 4 nanometers in diameter, but they are encapsulated in biocompatible microparticles that form spheres about 20 microns in diameter. This encapsulation allows the dye to remain in place, under the skin, after being injected. The researchers designed their dye to be delivered by a microneedle patch rather than a traditional syringe and needle. Such patches are now being developed to deliver vaccines for measles, rubella, and other diseases, and the researchers showed that their dye could be easily incorporated into these patches. The microneedles used in this study are made from a mixture of dissolvable sugar and a polymer called PVA, as well as the quantum-dot dye and the vaccine. When the patch is applied to the skin, the microneedles, which are 1.5 millimeters long, partially dissolve, releasing their payload within about two minutes. By selectively loading microparticles into microneedles, the patches deliver a pattern in the skin that is invisible to the naked eye but can be scanned with a smartphone that has the infrared filter removed. The patch can be customized to imprint different patterns that correspond to the type of vaccine delivered. “It’s possible someday that this ‘invisible’ approach could create new possibilities for data storage, biosensing, and vaccine applications that could improve how medical care is provided, particularly in the developing world,” Langer says. Effective immunization Tests using human cadaver skin showed that the quantum-dot patterns could be detected by smartphone cameras after up to five years of simulated sun exposure. The researchers also tested this vaccination strategy in rats, using microneedle patches that delivered the quantum dots along with a polio vaccine. They found that those rats generated an immune response similar to the response of rats that received a traditional injected polio vaccine. “This study confirmed that incorporating the vaccine with the dye in the microneedle patches did not affect the efficacy of the vaccine or our ability to detect the dye,” Jaklenec says. The researchers now plan to survey health care workers in developing nations in Africa to get input on the best way to implement this type of vaccination record keeping. They are also working on expanding the amount of data that can be encoded in a single pattern, allowing them to include information such as the date of vaccine administration and the lot number of the vaccine batch. The researchers believe the quantum dots are safe to use in this way because they are encapsulated in a biocompatible polymer, but they plan to do further safety studies before testing them in patients. “Storage, access, and control of medical records is an important topic with many possible approaches,” says Mark Prausnitz, chair of chemical and biomolecular engineering at Georgia Tech, who was not involved in the research. “This study presents a novel approach where the medical record is stored and controlled by the patient within the patient’s skin in a minimally invasive and elegant way.” The research was funded by the Bill and Melinda Gates Foundation Along with the vaccine, a child would be injected with a bit of dye that is invisible to the naked eye but easily seen with a special cell-phone filter, combined with an app that shines near-infrared light onto the skin. The dye would be expected to last up to five years, according to tests on pig and rat skin and human skin in a dish. The system—which has not yet been tested in children—would provide quick and easy access to vaccination history, avoid the risk of clerical errors, and add little to the cost or risk of the procedure, according to the study, published Wednesday in Science Translational Medicine. The research, conducted by M.I.T. bioengineers Robert Langer and Ana Jaklenec and their colleagues, uses a patch of tiny needles called microneedles to provide an effective vaccination without a teeth-clenching jab. Microneedles are embedded in a Band-Aid-like device that is placed on the skin creating an 'etch' a skilled nurse or technician is not required. Vaccines delivered with microneedles also may not need to be refrigerated, reducing both the cost and difficulty of delivery, Langer and Jaklenec say. Delivering the dye required the researchers to find something that was safe and would last long enough to be useful. “That’s really the biggest challenge that we overcame in the project,” Jaklenec says, adding that the team tested a number of off-the-shelf dyes that could be used in the body but could not find any that endured when exposed to sunlight. The team ended up using a technology called quantum dots, tiny semiconducting crystals that reflect light and were originally developed to label cells during research. The dye has been shown to be safe in humans. The researchers hope to add more detailed information to the dots, such as the date of vaccination. Along with them, the team eventually wants to inject sensors that could also potentially be used to track aspects of health such as insulin levels in diabetics, Jaklenec says. This approach is likely to be one of many trying to solve the problem of storing individuals’ medical information, says Ruchit Nagar, a fourth-year student at Harvard Medical School, who also was not involved in the new study. He runs a company, called Khushi Baby, that is also trying to create a system for tracking such information, including vaccination history, in the developing world. DESCRIPTION Luciferase is an enzyme, that produces light. It is present in insect fireflies and in luminous marine and terrestrial microorganisms. According to the King James Bible-based Strong's Concordance, the original Hebrew word Lucifer means "shining one, light-bearer", and the English translation given in the King James text is the Latin name for the planet Venus, "Lucifer", as it was already in the Wycliffe Bible. Quite a stretch of coincidence that the invention that fits the mark of the beast criteria relating to 'etch' and "mark" also uses a shortened term m for Lucifer namely Luciferase proteins are available in two forms, such as firefly (Photinus pyralis) and bacterial .Luciferase is a class of enzymes naturally found in organisms like protists, fungi, insects, bacteria which belong to phylogenic kingdom. It is used as a molecular marker for biological imaging as it specifically cleaves luciferin substrate which results in emitting light. Application Luciferase has been used as a component in Mix B respiration medium for the determination of the ATP synthetic activity of the H+-ATP synthase. It has also been used in thermal aggregation to assay CnoX (YbbN) activity. Biochem/physiol Actions Firefly luciferase oxidizes luciferin to oxyluciferin using molecular oxygen and ATP in the reaction and liberates light at 560 nm. Quality Contaminants: <1 mU ATPase/mg lyophilizate, and <10 mU nucleoside diphosphatase kinase/mg lyophilizate. The lyophilizate contains neither luciferin nor arsenate. More information to come